Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Biology Laboratory, |
RCV001281132 | SCV001425034 | pathogenic | Autosomal recessive Alport syndrome | 2020-02-01 | criteria provided, single submitter | research | |
RCV001290438 | SCV001478447 | likely pathogenic | Autosomal dominant Alport syndrome | 2021-02-08 | criteria provided, single submitter | clinical testing | This variant is a transition of thymine by cytosine in splicing site at intronic region 12 two position before start codificant region at exon 12 . Using ACMG criteria (PVS1, PM2, PP3) we clasified it like likely pathogenic variant. | |
Laboratorio de Genética Hospitales Universitarios Virgen de las Nieves y Clínico San Cecilio |
RCV001281132 | SCV002558693 | likely pathogenic | Autosomal recessive Alport syndrome | 2022-08-03 | criteria provided, single submitter | clinical testing | ACMG 2015 Criteria: PVS1, PM2, PP3 |
Fulgent Genetics, |
RCV005029843 | SCV005653622 | pathogenic | Autosomal recessive Alport syndrome; Hematuria, benign familial, 1 | 2024-05-21 | criteria provided, single submitter | clinical testing |